ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,712.73
      -0.28%
      US Tech 100
      19,453.20
      -0.23%
      Dow Jones
      41,794.60
      -0.61%
      Brent Oil
      75.245
      1.58%
      Bitcoin
      67,326.89
      -2.06%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX

      6. Calidi Biotherapeutics Inc (CLDI) Quote

      Calidi Biotherapeutics Inc

      Calidi Biotherapeutics Inc (CLDI)

      AMEX
      1.29
      -0.06
      ( -4.44% )
      Updated: 15:46:11
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      1.29
      Bid
      -
      Ask
      -
      Volume
      1,884,763
      1.15 Day's Range 1.37
      0.73 52 Week Range 26.30
      Market Cap
      12.751M
      Previous Close
      1.35
      Open
      1.37
      Last Trade
      200
      @
      1.29
      Last Trade Time
      15:46:11
      Financial Volume
      $ 2,396,174
      VWAP
      1.2713
      Average Volume (3m)
      353,537
      Shares Outstanding
      9,884,153
      Dividend Yield
      -
      PE Ratio
      -0.44
      Earnings Per Share (EPS)
      -2.96
      Revenue
      -
      Net Profit
      -29.22M

      About Calidi Biotherapeutics Inc

      The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the FLAGLSX-Forensic Accounting Long-Short Index. The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the FLAGLSX-Forensic Accounting Long-Short Index.

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.calidibio.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Calidi Biotherapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the American Stock Exchange with ticker CLDI. The last closing price for Calidi Biotherapeutics was $1.35. Over the last year, Calidi Biotherapeutics shares have traded in a share price range of $ 0.73 to $ 26.30.

      Calidi Biotherapeutics currently has 9,884,153 shares outstanding. The market capitalization of Calidi Biotherapeutics is $13.34 million. Calidi Biotherapeutics has a price to earnings ratio (PE ratio) of -0.44.

      Ask ADVFN Intelligence (AI)

      CLDI Latest News

      More News

      FeaturedNorth Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia

      7 hours ago

      Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences

      - RTNova, an innovative systemic antitumor enveloped virotherapy, unlocks new possibilities in cancer therapy - RTNova addresses challenges posed by untargetable and untreatable metastatic...

      October 24 2024
      GlobeNewswire Inc.

      Calidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement

      SAN DIEGO, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company developing a new generation of...

      October 23 2024
      GlobeNewswire Inc.

      NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS)

      SAN DIEGO, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted...

      October 18 2024
      GlobeNewswire Inc.

      Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 Clinical Trial in High-Grade Glioma

      Trial will evaluate multiple doses of CLD-101 for the treatment of newly diagnosed high-grade glioma CLD-101 is Calidi’s novel allogeneic immunotherapy utilizing neural stem cells to deliver...

      September 30 2024
      GlobeNewswire Inc.

      Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results

      Launched Nova Cell subsidiary with $2 million investment from Dr. Ronald Rigor to advance Calidi’s Adult Adipose Allogeneic (AAA) stem cell innovative programs Strengthened team with the...

      August 13 2024
      GlobeNewswire Inc.

      Calidi Biotherapeutics Announces Launch of Nova Cell Subsidiary and $3 Million Aggregate Investment from Dr. Ronald Rigor

      SAN DIEGO, July 29, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI or “Calidi”), a clinical-stage biotechnology company developing a new generation of targeted...

      July 29 2024
      GlobeNewswire Inc.

      Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform

      SAN DIEGO, July 18, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI or “Calidi”), a clinical-stage biotechnology company developing a new generation of targeted...

      July 18 2024
      GlobeNewswire Inc.

      Calidi to Effect Reverse Stock Split

      Calidi common stock expected to begin trading on a 1-for-10 split adjusted basis on July 15, 2024 Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi” or “Company”), a clinical-stage...

      July 05 2024
      Business Wire

      Calidi Biotherapeutics Announces Appointment of Cancer Immunotherapy Pioneer Dr. George Peoples to Board of Directors

      Calidi Biotherapeutics, Inc. (NYSE American: CLDI or “Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced the...

      June 27 2024
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.1816.21621621621.111.510.9717439481.21521366CS
      40.2422.85714285711.051.510.738768981.14253613CS
      12-0.47-26.70454545451.761.790.733535371.15721299CS
      26-0.62-32.46073298431.914.90.737851911.91988599CS
      52-18.71-93.552026.30.736607473.2255541CS
      156-43.81-97.139689578745.1500.735804193.57443122CS
      260-43.81-97.139689578745.1500.735804193.57443122CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      AAPYKurv Yield Premium Strategy Apple AAPL ETF
      $ 0.00
      (0.00%)
      		0
      AAPXT Rex 2X Long Apple Daily Target ETF
      $ 0.00
      (0.00%)
      		0
      AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026
      $ 0.00
      (0.00%)
      		0
      AAAUGoldman Sachs Physical Gold ETF Shares
      $ 0.00
      (0.00%)
      		0
      AAAAlternative Access First Priority CLO Bond ETF
      $ 0.00
      (0.00%)
      		0
      AAPYKurv Yield Premium Strategy Apple AAPL ETF
      $ 0.00
      (0.00%)
      		0
      AAPXT Rex 2X Long Apple Daily Target ETF
      $ 0.00
      (0.00%)
      		0
      AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026
      $ 0.00
      (0.00%)
      		0
      AAAUGoldman Sachs Physical Gold ETF Shares
      $ 0.00
      (0.00%)
      		0
      AAAAlternative Access First Priority CLO Bond ETF
      $ 0.00
      (0.00%)
      		0
      AAPYKurv Yield Premium Strategy Apple AAPL ETF
      $ 0.00
      (0.00%)
      		0
      AAPXT Rex 2X Long Apple Daily Target ETF
      $ 0.00
      (0.00%)
      		0
      AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026
      $ 0.00
      (0.00%)
      		0
      AAAUGoldman Sachs Physical Gold ETF Shares
      $ 0.00
      (0.00%)
      		0
      AAAAlternative Access First Priority CLO Bond ETF
      $ 0.00
      (0.00%)
      		0

      CLDI Discussion

      View Posts
      tw0122 tw0122 6 days ago
      Go again lol $1.17 back to .99
      Or ready to pump 
      👍️0
      totffe totffe 2 weeks ago
      Yep, golden opportunity!
      👍️0
      totffe totffe 2 weeks ago
      LOL, well no one is selling and the stock showed good gains end of week. Very bullish!
      👍️0
      ErnieBilco ErnieBilco 2 weeks ago
      They were not BUYS but option awards not one of them have exercised their right to buy at $1.09.

      It is not bullish at all
      👍️0
      Monksdream Monksdream 2 weeks ago
      CLDI under $2
      👍️0
      totffe totffe 3 weeks ago
      Fantastic buying opportunity. 6 company officers filed Form 4's last week, all buys. Bullish
      👍️0
      Monksdream Monksdream 4 weeks ago
      CLDI new 52 week low
      👍️ 1 😎 1
      Monksdream Monksdream 2 months ago
      CLDI under $2
      👍️0
      Monksdream Monksdream 2 months ago
      CLDI new 52=week low
      👍️0
      TrendTrade2016 TrendTrade2016 3 months ago
      CLDI..NEXT POST SPLIT BUCKAROO!!!!
      👍️0
      Monksdream Monksdream 3 months ago
      CLDI under $2
      👍️0
      Monksdream Monksdream 4 months ago
      CLDI under $2
      👍️0
      ErnieBilco ErnieBilco 4 months ago
      Probably because it is a worthless company that is heavily in debt and by all rights it should be kicked off the Nasdaq but Nasdaq urges these worthless companies to screw their shareholders to artificially get their stock price to $1 - I expect a landslide decline back to a quarter in short order.

      This is one of my bets that doesn't look like it will make me any money - unless they can somehow pump it up on the fact the the OS will be about 5 million shares on split day.

      Just my take on it after looking thru Q1 Quarterly report.
      👍️0
      JTORENCE JTORENCE 4 months ago
      Ernie Bilco You may have predicted right. Reverse splits are usually the death blow for a stock. Hope not. Why did they do this??
      👍️0
      Invest-in-America Invest-in-America 5 months ago
      CLDI: News --- collaboration with SIGA to kill all Cancers.
      👍️0
      Termite7 Termite7 5 months ago
      Keeping an eye...... coiled!!!
      👍️0
      accipiterr accipiterr 6 months ago
      April 24th webinar
      https://redchip.zoom.us/webinar/register/WN_qT-PBRbTQ0yLeBbJ4jzPSw
      in this one they mention 3 different times that they are talking to large pharmaceutical companies about licencing and about how the recent data, specifically for RTnova, has resulted in high level discussions with more planned in the near future.


      May 9th webinar
      https://sidoti.zoom.us/webinar/register/WN_p8GBAbbqTd2OuYnM33eTuQ#/registration
      👍️0
      accipiterr accipiterr 6 months ago
      Bottom in, looks ready for a move up. Data being presented on June 1st.
      👍️0
      ErnieBilco ErnieBilco 6 months ago
      Yikes, RedChip is usually the kiss of death for all the stocks they have pumped or paid promoted
      👍️0
      Legend431 Legend431 7 months ago
      Looking good
      👍️0
      Triple nickle Triple nickle 7 months ago
      Here we gooooo
      👍️0
      2020trader 2020trader 7 months ago
      DOWN 6% TODAY....EXPECTING LOWER
      👍️0
      glenn1919 glenn1919 8 months ago
      CLDI................................................https://stockcharts.com/h-sc/ui?s=CLDI&p=W&b=5&g=0&id=p86431144783
      👍️0

      Your Recent History

      AMEX
      CLDI
      Calidi Biotherapeutics
      AMEX
      BBUS
      JPMorgan BetaBuilders US...
      BOV
      PULV11
      Fund De Invest Imobiliar...
      LSE
      NVD2
      Ls 2x Nvidia
      AQSE
      BSP
      Black Sea Property
      LSE
      65OK
      Mound Fin.4 1ba
      LSE
      FRNC
      Framlington Income
      ASX
      INL
      Innlanz
      Delayed Upgrade Clock